Why have microRNA biomarkers not been translated from bench to clinic?

Future Oncol. 2019 Mar;15(8):801-803. doi: 10.2217/fon-2018-0812. Epub 2019 Jan 17.

Authors

Kioomars Saliminejad¹, Hamid Reza Khorram Khorshid², Seyed Hamidollah Ghaffari¹

Affiliations

¹ Hematology, Oncology & Stem Cell Transplantation Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
² Genetics Research Center, University of Social Welfare & Rehabilitation Sciences, Tehran, Iran.

PMID: 30652506
DOI: 10.2217/fon-2018-0812

No abstract available

Keywords: NGS; biomarker; cancer; circulating microRNA; clinical; diagnosis; plasma; profiling; prognosis; serum.

Publication types

Editorial

MeSH terms

Biomarkers*
Circulating MicroRNA
Gene Expression Regulation*
Genetic Association Studies
Humans
MicroRNAs / genetics*
Neoplasms / blood
Neoplasms / diagnosis
Neoplasms / genetics
Prognosis
RNA Interference*
Translational Research, Biomedical* / methods

Substances

Biomarkers
Circulating MicroRNA
MicroRNAs